CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Nicolas J. Schlienz - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Nicolas J. Schlienz

OPENALEX: A5022528069↗ORCID: 0000-0003-3665-6776↗

Affiliations

Organizations

Behavioral Pharma (United States)authorship · US Johns Hopkins Medicineauthorship · US Johns Hopkins Universityauthorship · US Roswell Park Comprehensive Cancer Centerauthorship · US University at Buffalo, State University of New Yorkauthorship · US

Public evidence

5 connected articles

Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors.2024 · Europe PMC Online survey of medicinal cannabis users: Qualitative analysis of patient-level data.2022 · Europe PMC Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial.2021 · Europe PMC A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health.2021 · PubMed Central Open Access "Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.2018 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.